intuitive surgical investor presentation 2021

Submit. For more information, please visit the Companys website at www.intuitive.com. INTUITIVE at 43rd Annual Goldman Sachs Global Healthcare Conference. Making the world smarter, happier, and richer. Intuitive(Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Mai 2022: CI. Yeah, sure. Unrealized gain (loss) - net of tax expense (recovery) effect of $347 and $37 for the three months ended December 31, 2022 and 2021, respectively; ($859) and $(354) for the six months ended . Third, we are launching and refining our flexible diagnostic platform, Ion, by working with early customers to help establish high-performing sites and by improving our technology and supply chain capabilities. The fourth quarter 2021 system shipments included 143systems shipped under operating lease and usage-based arrangements, compared with 120 systems in thefourth quarter of 2020. Gross profit, income from operations, net income attributable to Intuitive Surgical, Inc., and net income per diluted share attributable to Intuitive Surgical, Inc. are reported on a GAAP and non-GAAP* basis. Jamie Samath Senior Vice President of Finance Those things are ongoing now. The compound annual revenue growth rate between the second quarters of 2019 and 2021 was 15%. There are a number of limitations related to the use of non-GAAP measures versus measures calculated in accordance with GAAP. Pagination. Instrument and accessory revenue per procedure of $1,940 increased, compared with $1,900 per procedure for the second quarter of last year, and decreased, compared with $1,950 per procedure in the first quarter. Intuitive Surgical (ISRG) Posts Robust Preliminary Q4 Results Global Minimally Invasive Prostate Cancer Surgery Market Analysis by Please go ahead, sir. Our SEC filings can be found through our website or at the SEC's website. The Company excludes the excess tax benefits or deficiencies associated with SBC arrangements as well as the tax effects associated with non-cash amortization of deferred tax assets related to intra-entity non-inventory transfers, because the Company does not believe these items correlate with the on-going results of its core operations. Reported revenue and procedure results are consistent with the Companys press release issued on January 12, 2022. Fourth quarter 2022 instruments and accessories revenue increased by 12% to $941 million, compared with $843 million in the fourth quarter of 2021. We are building tools and capabilities that allow hospital departments and departments of surgery to manage their program and look across programmatics for efficiency, for learning, for outcomes, and these things interlink. From the low-end perspective, the 27% reflected there is greater summer seasonality that reflects the possibility of an impact due to pent-up demand for vacation, especially for healthcare workers that have worked extensively during this period with COVID. First, we are broadening access to our advanced instruments for our da Vinci Fourth Generation Multiport Systems through pursuit of additional clearances and launches outside the U.S. Second, we are expanding our da Vinci SP offering by broadening its regional and clinical indications and by adding it to its suite of instruments and accessories. INTUITIVE SURGICAL, INC.UNAUDITED QUARTERLY CONDENSED CONSOLIDATED STATEMENTS OF INCOME(IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED TWELVE MONTHS ENDED CONDENSED CONSOLIDATED STATEMENTS OF INCOME(IN MILLIONS, EXCEPT PER SHARE DATA), INTUITIVE SURGICAL, INC.UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS(IN MILLIONS), INTUITIVE SURGICAL, INC.UNAUDITED RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES(IN MILLIONS, EXCEPT PER SHARE DATA), Contact: Investor Relations(408) 523-2161. And so we watch that number because we know it's highly sensitive. The decrease relative to these prior periods reflects geographic mix and volume discounts provided to customers purchasing multiple systems. Second-quarter system average selling prices decreased to $1.55 million from $1.65 million for both the second quarter of 2020 and the first quarter of 2021. I'm just curious what the net effect there is from the savings and expense perspective and R&D, whether this is maybe the beginning of you starting to see some leverage off of the 10% you've been at for the last couple of years. These non-GAAP financial measures also facilitate managements internal comparisons to its historical performance. Intuitive Surgical jumps past $100 billion market value as 1st-quarter Minimum 15 minutes delayed. In the United States, procedure growth was strong in the quarter, driven by growth in bariatric surgery, hernia repair, and cholecystectomy. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.neuropace.com, on the Investors page in the News & Events section. We have a broad range of estimates. Gosh, that's awfully encouraging sounding. Second-quarter revenue reflected growth in both procedures and system placements. However, to gain a more complete understanding of the body of evidence, we encourage all stakeholders to thoroughly review the extensive detail of scientific studies that have been published over the years. There are several models of the da Vinci Surgical System. In fact, our commentary is a little bit the opposite that these are being highly utilized. You go from an issue to identification to closure more quickly. A couple of things I'd say. Q4 2022 INTUITIVE Earnings Conference Call, INTUITIVE at J.P. Morgan Healthcare Conference, Q3 2022 INTUITIVE Earnings Conference Call, INTUITIVE at 2022 Wells Fargo Healthcare Conference, Q2 2022 INTUITIVE Earnings Conference Call, INTUITIVE at 43rd Annual Goldman Sachs Global Healthcare Conference, INTUITIVE at BofA Securities 2022 Healthcare Conference, Q1 2022 INTUITIVE Earnings Conference Call. Our actual gross profit margin will vary quarter to quarter depending largely on product, regional, and trade-in mix, the impact of product cost reductions, and manufacturing efficiencies and pricing pressure. So we're making those investments to move that forward. Second-quarter 2021 OUS procedure growth was driven by growth in prostatectomy procedures and earlier-stage growth in kidney cancer procedures, general surgery, gynecology, and thoracic. Today's press release and supplementary financial data tables have been posted to our website. The split must be approved by the shareholders but this is merely a formality. It links into some of the other things you're talking about. We ended the quarter with cash and investments of $7.7 billion, compared with $7.2 billion last quarter. And we expect those to come back as COVID goes away and the restrictions on travel and the restrictions on other activities go away. We also believe that growth benefited from some procedures that were previously deferred due to delays in testing and patient concern over COVID. From a U.S. perspective, I think it's early, and I think we're simply acknowledging the risk. Add to that, the uncertainty of wave 4, possibility of wave 4 makes it tough to put a number on, Larry. Looking at the past eight quarters in context, our compound annual growth rate for procedures for the period Q2 2019 through Q2 2021 of 16.5% is approximately the growth we would have expected absent the pandemic. Fourth quarter 2022 non-GAAP* income from operations decreased to $530 million, compared with $583 million in the fourth quarter of 2021. It's hard to have a precise measure on it. Intuitive Surgical, Inc. (ISRG) CEO Gary Guthart - SeekingAlpha Please go ahead. (1) Services revenue includes the effect of the following item: (2) Selling, general and administrative includes the effect of the following item: (3) Income from operations includes the effect of the following item: (4) Interest and other income, net includes the effect of the following item: (5) Income tax expense includes the effect of the following items: Excess tax benefits related to share-based compensation arrangements. But at this point, it's just too difficult to estimate and, therefore, kind of give you any additional color on. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Marshall L. Mohr Executive Vice President and Chief Financial Officer. J Global Clinical Engineering, Special Issue 4, 2021 - Proceedings IV ICEHTMC 2021 - ISSN 2578 2762 1 dicembre 2021 . The authors concluded, "The results revealed that robotic-assisted thoracic surgery is a feasible and safe technique compared with VATs in terms of short-term and long-term outcomes." Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. EMCOR Group, Inc. (NYSE:EME) Q4 2022 Earnings Call Transcript Thirty-eight percent of systems placed in the second quarter involved trade-ins, which is lower than the 40% last year and the 44% last quarter. The non-GAAP* measures are described below and are reconciled to the corresponding GAAP measures at the end of this release. Intuitive | ISRG in the News Our actual tax rate will fluctuate with changes in the geographic mix of income, changes in taxation made by local authorities, and with the impact of one-time items. Non-GAAP gross profit. They're giving their PowerPoints about what they think is going to happen next and some other things. I hear your question is asking us how much is left, how much of the catch-up is left. In the U.S., Q2 procedure results were positively impacted by a continuing recovery from COVID-19, including, we believe, a number of procedures that had been previously deferred. How close we are to maybe seeing something that you can monetize? Annualized U.S. procedure growth rates are returning to historical levels for procedures with longer diagnostic pipelines as patients have started returning to screening and diagnostic testing. And I have one follow-up. Intuitive Announces Fourth Quarter Earnings, www.intuitive.com/en-us/products-and-services/ion, Less: net income (loss) attributable to noncontrolling interest in joint venture. Intuitive Surgical's Q3 2021 adjusted earnings per share (EPS) is expected to be $1.22 per Trefis analysis, slightly above the consensus estimate of $1.17. We expanded our installed base of da Vinci Systems over the last year by 10% to approximately 6,335 systems. While this did not have a material impact to our operating results in Q2, the outlook we are providing does not reflect any potential significant disruption or additional costs related to supply constraints. And U.S. general surgery, in particular, performed well. So it's hard to time it out, and it doesn't time out over one or two quarters, it times out over years. Attendees can engage with peers, connect with Intuitive resource teams, and explore innovative robotic-assisted technology spanning the care continuum. From the top, I think you said the right thing, which is there's a little bit of a decoupling thus far of infection from hospitalization. Moving on to gross margin and operating expenses. SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2021.Reported revenue and procedure results are consistent with the Company's press release issued on January 12, 2022. Customer appreciation and recurring use of our products has been growing nicely. Intuitive Surgical 10.5. Copyright 2023 Intuitive Surgical. That says that we're not putting out more capital than folks need, even though it's been healthy capital quarters, it means our customers are getting good benefit out of what they're using those systems for. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2022 $580 calls on Intuitive . Fourth quarter 2022 constant currency revenue increased 10% compared to the fourth quarter of 2021. The company strives to make surgery more effective, less invasive and easier on surgeons, patients and their families. Our total Ion clinical experience is approximately 4,000 cases to date. Or is it too early, and you're just saying that might happen in the future? We recognized $26 million of lease buyout revenue in the second quarter, compared with $9 million last year and $19 million last quarter. We think we can bring some outstanding imaging capabilities, including florescence imaging into that space. At the "Pitching to Investors Programme" you will have an exclusive 10-minute pitching slot on stage for you to showcase your company to our entire audience and the biggest community of investors. The year-over-year increase in I&A revenue per procedure reflects increased usage of our advanced instruments, partially offset by the impact of extended use instruments. General surgery growth in the U.S. was strong, and in addition to the positive impact from patient backlogs, reflected increasing access for surgeons to our fourth-generation technology. User Experience for digital health innovations:<br>I work with startups and corporations and design user-centered products, services, and digital business models. Q2 2022 INTUITIVE Earnings Conference Call. We don't actually know how much backlog was resolved in the quarter, how much backlog is left or the timing of the recovery of that might be. Intuitive Surgical's adjusted net . To change your e-mail options at And just, you know, on competition, it does seem like the noise is increasing. Intuitive develops, manufactures and markets the da Vinci surgical system. Congrats on the quarter. Philip Kim, our head of investor relations, will not be joining on today's call as he's currently on paternity leave following the birth of his daughter. We've seen a few teams come out and field systems that are alternatives to ours. And at this time, I would like to turn the conference over to our host, senior director of finance, investor relations for Intuitive, Mr. Calvin Darling.

Bill Murray On Harold Ramis' Death, Tesla Model S Door Handles Not Presenting, Ambetter Mhs Provider Portal, Articles I

intuitive surgical investor presentation 2021